Global Neurostimulation Devices Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3600/- USD | Published Date: October 30, 2020 |

The global neurostimulation devices market size was estimated at over USD 5 billion in 2019 and projected to grow at the CAGR of 13.15% during 2020-2027. Neurostimulation involves modulation or stimulation of neural processes. Growth in the geriatric population, the incidence of chronic pain, neurological diseases such as Parkinson’s disease, and Alzheimer’s disease have presented significant proliferation opportunities for neurostimulation devices. In the future, it is expected that the progress of the neurostimulation devices market will be facilitated by utilization of the lucrative opportunities present in emerging markets of Middle East and Africa, Latin America and Asia Pacific, and further evolution of implantable devices.

Market Insights:

Perpetual growth in the incidence of chronic pain, neurological disorders, and growing awareness about the management of debilitating neurological diseases are the key factors driving the demand for neurostimulation devices. Huge set of unmet needs between the ever-growing patient pool and the efficacy of available treatment options further intensifies the need for more efficient neurostimulation devices in the market. Neurosurgeons and researchers worldwide are on the lookout for developing enhanced surgical modalities that are less complex in nature, minimally invasive, and offer longer efficacy. This report on the neurostimulation devices market offers extensive scrutiny of this market in terms of market size, standard segmentation, geographical markets, overall market trends, and market dynamics.

Among the several therapeutic areas where neurostimulation is preferred, pain management forms the largest revenue-generating segment. The high prevalence of chronic pain, growing surgical procedures, escalating senescent population are the major factors that have influenced the rise in demand for neurostimulation for pain management.

Market Segment Insights:

Based on the therapeutic areas, the global neurostimulation devices market is segmented into epilepsy, essential tremor, depression, dystonia, pain management, urinary and fecal incontinence, Parkinson’s disease, gastroparesis, and others. Among these, pain management is anticipated to remain the largest segment through the forecast period. Furthermore, the Parkinson’s disease segment is anticipated to progress at the fastest CAGR due to improving the success rate of neurostimulation devices in treating neurological conditions. Other conditions such as epilepsy, migraine, etc. are anticipated to attract more attention from patients and physicians for neurostimulation treatments majorly due to the rising patient population in this category.

Deep brain stimulators, spinal cord stimulations, gastric electric stimulators, vagus nerve stimulators, and sacral nerve stimulators studied in the scope of this report. The market size of spinal cord stimulation is observed to be the largest among the considered stimulation types. Wide therapeutic application of spinal cord stimulation and intense market penetration are the key factors contributing to the dominance of the spinal cord stimulators segment. Further technological innovation and expansion in the therapeutic scope will augment the reach of this segment during the forecast period. On the other hand, deep brain stimulators are anticipated to be rapidly adopted in the global market particularly for treating peculiar neurological conditions.

Global Neurostimulation Devices Market Segmentation:

By Type, 2018–2027 ($ Millon)

  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Gastric Electric Stimulators

By Therapeutic Area, 2018–2027 ($ Millon)

  • Pain Management
  • Epilepsy
  • Essential Tremors
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson’s Disease
  • Others

By Geography, 2018-2027 ($ Millon)

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Regional Insights:

Based on regional distribution, the global neurostimulation devices market is categorized into North America (U.S., Canada), Europe (U.K., Germany, Rest of Europe), Asia Pacific (Japan, China, Rest of Asia Pacific), Latin America (Brazil, Mexico, Rest of Latin America) and Middle East and Africa (Saudi Arabia, South Africa, Rest of MEA). Among the considered regional markets, North America accounted for the largest share followed by Europe. Significant unmet needs in Middle East and Africa and Asia Pacific will attract the attention of manufacturers of neurostimulation devices. An increase in healthcare expenditure, the evolution of healthcare infrastructure, and the growing availability of skilled personnel in these regions are anticipated to be the most significant drivers.

Market Competition Assessment:

The major players currently operating in the global neurostimulation devices market include Boston Scientific Corporation, Cyberonics, Cogentix Medical, and others.

List of Key Companies:

  • Boston Scientific Corporation
  • Cogentix Medical
  • Codman & Shurtleff, Inc.
  • Cyberonics
  • IntraPace, Inc.
  • Medtronic
  • Neuronetics, Inc.
  • Nevro Corp
  • Jude Medical

Request a full report sample to review @

Key Questions Answered by Neurostimulation Devices Market Report

  • Global neurostimulation devices market forecasts from 2020-2027
  • Regional neurostimulation devices market forecasts from 2020-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2020-2027 covering 15 major countries from the aforementioned regions
  • Neurostimulation devises submarket forecasts from 2020-2027 covering the market by type, by therapeutic area, and geography
  • Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to neurostimulation devices market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country-level neurostimulation devices markets from 2020-2027
  • Competitive Landscape and market positioning of top 10 players operating in the neurostimulation devices market

Table of Content:

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Neurostimulation Devices Market Portraiture
2.2 Global Neurostimulation Devices Market, by Type, 2019
2.3 Global Neurostimulation Devices Market, by Therapeutic Area, 2019
2.4 Global Neurostimulation Devices Market Share, by Geography, 2019
Chapter 3 Global Neurostimulation Devices Market Overview
3.1 Overview
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Market Competition Assessment: Neurostimulation Devices Market, by Key Players
Chapter 4 Global Neurostimulation Devices Market, By Type, 2018-2027 ($ Million)
4.1 Introduction
4.2 Spinal Cord Stimulators
4.3 Deep Brain Stimulators
4.4 Sacral Nerve Stimulators
4.5 Vagus Nerve Stimulators
4.6 Gastric Electric Stimulators
Chapter 5 Global Neurostimulation Devices Market, By Therapeutic Areas, 2018-2027 ($ Million)
5.1 Introduction
5.2 Pain Management
5.3 Epilepsy
5.4 Essential Tremors
5.5 Urinary and Fecal Incontinence
5.6 Depression
5.7 Dystonia
5.8 Gastroparesis
5.9 Parkinson’s Disease
5.10 Others
Chapter 6 Global Neurostimulation Devices Market, By Geography, 2018-2027 ($ Million)
6.1 Preface
6.2 North America (U.S., Canada)
6.3 Europe (U.K., Germany, Rest of Europe)
6.4 Asia Pacific (Japan, China, Rest of Asia Pacific)
6.5 Latin America (Brazil, Mexico, Rest of LATAM)
6.6 Middle East and Africa (Saudi Arabia, South Africa, Rest of MEA)
Chapter 7 Company Profiles
7.1 Medtronic
7.2 St. Jude Medical
7.3 Boston Scientific Corporation
7.4 Cyberonics
7.5 Nevro Corp
7.6 Cogentix Medical
7.7 Neuronetics, Inc.
7.8 IntraPace, Inc.
7.9 Codman & Shurtleff, Inc.
Fill the given form to inquiry before buying for Neurostimulation Devices Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample
Inquiry Before Buying

Select License Type
$3600/- Single User License
$2520 (30% Discount for Single User)
$4800/- Multi User License
$3360 (30% Discount for Multi-User)
$6800/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 100+ countries analyzed granularly
  • 35% of our total client are returning clients
  • 1000+ customers globally
  • 100+ paid data sources mined to bring cutting-edge insights
  • 24x5 availability - we are always there when you need us
  • "Free of Cost Report Customization" is available
  • Request a regional report at Best Price
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report

Impacts of COVID-19
COVID-19 Impact on the Neurostimulation Devices Market

Our Clients